Mankind Pharma Ltd Screener
Large Cap
With a marketcap of ₹ 1,20,457.16 Cr Stock is ranked 72
Mankind Pharma Investment Return
Short Term
1.33 %
10.55 %
14.07 %
41.63 %
Long Term
45.90 %
Mankind Pharma Return Calculator
₹
Mankind Pharma Revenue and Profit and Growth
- The company's Book Value Per Share (BVPS) is improving consistently for last 2 years
- The company's Operating Cash Flow is improving with good durability
- The company's net cash flow is improving for last 2 quarters.
- The company is showing good quarterly growth with YoY Net Profit Growth of 21.96%, the YoY Revenue Growth of 27.91% and the NetProfit for the last quarter of Rs. 1147.92 Cr.
- Annual Net Profits is increasing for 3 consecutive years
- There is an increase in the provisions made by the company.as per its recent filings.
- Mutual Funds have decreased their shareholding last quarter in the company
